ATP ion channel P2X purinergic receptors in inflammation response.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 17 11 2022
revised: 19 12 2022
accepted: 30 12 2022
entrez: 14 3 2023
pubmed: 15 3 2023
medline: 16 3 2023
Statut: ppublish

Résumé

Different studies have confirmed that P2X purinergic receptors play a key role in inflammation. Activation of P2X purinergic receptors can release inflammatory cytokines and participate in the progression of inflammatory diseases. In an inflammatory microenvironment, cells can release a large amount of ATP to activate P2X receptors, open non-selective cation channels, activate multiple intracellular signaling, release multiple inflammatory cytokines, amplify inflammatory response. While P2X4 and P2X7 receptors play an important role in the process of inflammation. P2X4 receptor can mediate the activation of microglia involved in neuroinflammation, and P2X7 receptor can mediate different inflammatory cells to mediate the progression of tissue-wide inflammation. At present, the role of P2X receptors in inflammatory response has been widely recognized and affirmed. Therefore, in this paper, we discussed the role of P2X receptors-mediated inflammation. Moreover, we also described the effects of some antagonists (such as A-438079, 5-BDBD, A-804598, A-839977, and A-740003) on inflammation relief by antagonizing the activities of P2X receptors.

Identifiants

pubmed: 36916431
pii: S0753-3322(22)01594-3
doi: 10.1016/j.biopha.2022.114205
pii:
doi:

Substances chimiques

Cytokines 0
Ion Channels 0
Receptors, Purinergic P2X4 0
Receptors, Purinergic P2X7 0
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114205

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Ji-Peng Liu (JP)

Department of Gastrointestinal surgery, The Second Affiliated Hospital, Nanchang University, Nanchang City, Jiangxi Province 343000, China.

Si-Cheng Liu (SC)

Department of Gastrointestinal surgery, The Second Affiliated Hospital, Nanchang University, Nanchang City, Jiangxi Province 343000, China.

Shi-Qi Hu (SQ)

Queen Mary College, Nanchang University, Nanchang City, Jiangxi Province 343000, China.

Jia-Feng Lu (JF)

Basic medical school, Nanchang University, Nanchang City, Jiangxi Province 343000, China.

Chang-Lei Wu (CL)

Department of Gastrointestinal surgery, The Second Affiliated Hospital, Nanchang University, Nanchang City, Jiangxi Province 343000, China.

Dong-Xia Hu (DX)

Department of Rehabilitation Medicine, The Second Affiliated Hospital, Nanchang University, Nanchang City, Jiangxi Province 343000, China. Electronic address: hudongxia5489@sina.com.

Wen-Jun Zhang (WJ)

Department of Rehabilitation Medicine, The Second Affiliated Hospital, Nanchang University, Nanchang City, Jiangxi Province 343000, China. Electronic address: 707384731@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH